# Elligo Health Research

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/elligo-health-research

- Industry: Biotechnology
- Headquarters: Austin, US
- Website: www.elligohealthresearch.com
- Total disclosed funding: $176M
- Latest round: Series E (Sep 23, 2021)
- Investors on record: 11

## About

Founded in 2016 and based in Texas, US, Elligo Health Research, Inc. is a medical research company that uses healthcare data to find and identify eligible physicians and patients for clinical trials. Mr. Chad Moore founded the company and has raised four venture capital financing from private equity investors, including Noro-Moseley Partners, Hatteras Venture Partners, and Excelerate Health Ventures. In September 2021, Morgan Stanley Expansion Capital and Ally Bridge Group co-led a USD 135 million in Series E funding for Elligo Health Research, Inc.

The company offers the Goes Direct approach and novel IntElligo Research Stack, a platform that identifies and provides a diverse population for clinical trials and research on new pharmaceutical, biotechnology, medical device, and diagnostic products. The platform also enables physicians to access over 150 million patients and their data through a platform that executes traditional site-based, hybrid, and decentralized clinical trial models.

Elligo Health Research, Inc. plans to use the September 2021 funding to acquire ClinEdge and invest further in the company's technology and data platform.

## Funding rounds

- Series E, Sep 23, 2021, $135M — Noro-Moseley Partners, Norwest Venture Partners, Hatteras Venture Partners, Piper Sandler, Morgan Stanley Expansion Capital, Cerner Corporation, Ally Bridge Group, Shumway Capital, Syneos Health, Inc.
- Series C, May 7, 2019, $20M — Noro-Moseley Partners, Hatteras Venture Partners, Piper Sandler, Excelerate Health Ventures, Shumway Capital, FS Healthcare
- Series B, Mar 15, 2018, $16M — Noro-Moseley Partners, Hatteras Venture Partners, Excelerate Health Ventures, Shumway Capital
- Series A, May 23, 2017, $5.3M — Shumway Capital

## Investors

- Shumway Capital (https://capitalatlas.ai/funds/shumway-capital) — Series A, Series B, Series C, Series E
- Noro-Moseley Partners (https://capitalatlas.ai/funds/noro-moseley-partners) — Series B, Series C, Series E
- Hatteras Venture Partners (https://capitalatlas.ai/funds/hatteras-venture-partners) — Series B, Series C, Series E
- Excelerate Health Ventures (https://capitalatlas.ai/funds/excelerate-health-ventures) — Series B, Series C
- Piper Sandler (https://capitalatlas.ai/funds/piper-sandler) — Series C, Series E
- FS Healthcare — Series C
- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series E
- Morgan Stanley Expansion Capital (https://capitalatlas.ai/funds/morgan-stanley-expansion-capital) — Series E
- Cerner Corporation — Series E
- Ally Bridge Group (https://capitalatlas.ai/funds/ally-bridge-group) — Series E
- Syneos Health, Inc. — Series E